Predicting in vivo drug interactions from in vitro drug discovery data
3rd Oct 2005, 19:37 GMT
Larry C. Wienkers and Timothy G. Heath
Predicting in vivo drug interactions from in vitro drug discovery data related news:
- [Immunology] Innate signals compensate for the absence of PKC-{theta} during in vivo CD8+ T cell effector and memory responses — Proceedings of the National Academy of Sciences recent issues
- Navigating the Concentration Curves: Pharmacologic Considerations in the Treatment of HIV — Medscape Headlines
- From the analyst's couchDrug discovery alliances — news@nature.com Drug Discovery channel
- Volume 41, number 9: In Vitro Activity of Fluoroquinolones against Mycoplasma genitalium and Their Bacteriological Efficacy for Treatment of M. genitalium-Positive Nongonococcal Urethritis in Men — Clin Infect Dis Latest Issue
- Venture capital is critical for new biotech firm — bizjournals.com Health Care:Biotechnology headlines
- Microplate products for drug discovery — Microplates/microarrays and readers latest news on Laboratorytalk
- News featurePainful lessons — news@nature.com Drug Discovery channel
- From the analyst's couch: Drug discovery alliances — Nature Reviews Drug Discovery
- An Audience With: Joanna Haas — news@nature.com Drug Discovery channel
- FDA to Clarify Drug Safety Reporting — Biohealthmatics.com Editor's News Headlines Picks